ClinicalTrials.Veeva

Menu

Trimester Sequential Estimation of Serum Zonulin as a Predictor of Gestational Diabetes Mellitus

B

Benha University

Status

Completed

Conditions

Gestational Diabetes

Treatments

Diagnostic Test: ELISA

Study type

Interventional

Funder types

Other

Identifiers

NCT06336512
RC.28.1.2024

Details and patient eligibility

About

Gestational diabetes mellitus (GDM) is the development of glucose intolerance (GI) during pregnancy in a previously normoglycemic (NG) woman and associated with insulin resistance (IR). GDM is the most prevalent metabolic disorder during pregnancy and became a major public health problem for being usually diagnosed and detected after 24 gestational weeks (GW), while its complications can occur much earlier and this may explain its burden on maternal and fetal welfare. Human zonulin is a surrogate marker of intestinal permeability and can be utilized as biomarker for intestinal barrier function. Zonulin-mediated increase in intestinal permeability plays a role in the pathogenesis of insulin resistance, obesity, DM and metabolic syndrome. The increasing global prevalence of GDM with its associated risk of poor pregnancy and long-term risks for the mother and the offspring may lead to the production of new generation of diabetics.

Enrollment

70 patients

Sex

Female

Ages

22 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Pregnant Women with singleton fetus

Exclusion criteria

  • Women with morbid obesity with body mass index ≥35 kg/m2;
  • Had manifest DM, irrespective of being controlled or not;
  • Bowel-related disorders;
  • Autoimmune disorders;
  • History of previous GDM.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

70 participants in 1 patient group

serum zonulin
Other group
Treatment:
Diagnostic Test: ELISA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems